Structural alterations in subcutaneous small resistance arteries predict changes in the renal function of hypertensive patients

Journal of Hypertension

Volumn 28, Issue 9, 2010, Pages 1951-1958

  Boari, Gianluca Em ^a   Rizzoni, Damiano ^a   De Ciuceis, Carolina ^a   Porteri, Enzo ^a   Avanzi, Daniele ^a   Platto, Caterina ^a   Mazza, Monica ^a   Brignani, Alida ^a   Rosei, Claudia Agabiti ^a   Ricotta, Doris ^a   Caimi, Luigi ^a   Rosei, Enrico Agabiti ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

media to lumen ratio; renal function; resistance sized arteries; serum creatinine; vascular remodeling

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITROGEN; ORAL ANTIDIABETIC AGENT; UREA; URIC ACID;

ANTIHYPERTENSIVE THERAPY; ARTERY; ARTICLE; BIOPSY TECHNIQUE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISSECTION; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY FUNCTION; LABORATORY TEST; MULTIVARIATE ANALYSIS; MYOGRAPHY; OBESITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PULSE PRESSURE; SMOKING; SUBCUTANEOUS FAT; SUBCUTANEOUS SMALL RESISTANCE ARTERY; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL;

EID: 77955851986     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833c2177     Document Type: Article

References (48)

1. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62:347-504.
2. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 1990; 70:921-961.
3. Borders JL, Granger HJ. Power dissipation as a measure of peripheral resistance in vascular networks. Hypertension 1986; 8:184-191.
4. Bohlen HG. Localization of vascular resistance changes during hypertension. Hypertension 1986; 8:181-183.
5. Lévy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. Microcirculation in hypertension: a new target for treatment? Circulation 2001; 104:735-740.
6. Mulvany MJ. Small artery remodeling and significance inthe development of hypertension. News Physiol Sci 2002; 17:105-109.
7. Schofield I, Malik R, Izzard A, Austin C, Heagerty AM. Vascular structural and functional changes in type 2 diabetes mellitus. Evidence for the role of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002; 106:3037-3043.
8. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, et al. Prognostic significance of small-artery structure in hypertension. Circulation 2003; 108:2230-2235.
9. Mathiassen ON, Buus NH, Sihm I, Thybo NK, Mørn B, Schroeder AP, et al. Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 2007; 25:1021-1026.
10. De Ciuceis C, Porteri E, Rizzoni D, Rizzardi N, Paiardi S, Boari GE, et al. Structural alterations of subcutaneous small-resistance arteries may predict major cardiovascular events in patients with hypertension. Am J Hypertens 2007; 20:846-852.
11. Rizzoni D, Palombo C, Porteri E, Muiesan ML, Kozàkovà M, La Canna G, et al. Relationships between coronary vasodilator capacity and small artery remodeling in hypertensive patients. J Hypertens 2003; 21:625-632.
12. Rizzoni D, De Ciuceis C, Porteri E, Paiardi S, Boari GE, Mortini P, et al. Altered structure of small cerebral arteries in patients with essential hypertension. J Hypertens 2009; 27:838-845.
13. Levy BI, Schiffrin EL, Mourad JJ, Agostini D, Vicaut E, Safar ME, Struijker-Boudier HA. Impaired tissue perfusion: a pathology commonto hypertension, obesity, and diabetes mellitus. Circulation 2008; 118:968-976.
14. Imig JD, Inscho EW. Adaptations of the renal microcirculation to hypertension. Microcirculation 2002; 9:315-328.
15. Johnson RJ, Rodriguez-Iturbe B, Schreiner GF, Herrera-Acosta J. Hypertension: a microvascular and tubulointerstitial disease. J Hypertens 2002; 20(Suppl 3):S1-S7.
16. Ruilope L, Rodicio JL. Renal participation in cardiovascular risk in essential hypertension. Blood Press 2001; 10:322-326.
17. Norrelund H,Christensen KL, SamaniNJ, Kimber P,Mulvany MJ, Korsgaard N. Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension 1994; 24:301-308.
18. Berecek KH, Schwertschlag U, Gross F. Alterations in renal vascular resistance and reactivity in spontaneous hypertension of rats. Am J Physiol 1980; 238:H287-H293.
19. Skov K, Mulvany MJ. Structure of renal afferent arterioles in the pathogenesis of hypertension. Acta Physiol Scand 2004; 181:397-405.
20. Skov K, Mulvany MJ, Korsgaard N. Morphology of renal afferent arterioles in spontaneously hypertensive rats. Hypertension 1992; 20:821-827.
21. Agabiti-Rosei E, Porteri E, Rizzoni D. The microvascular nature of hypertensive nephropathy. Microcirc Cardiovasc Dis 2005; 11:4-9.
22. van Hooft IM, Grobbee DE, Derkx FH, de Leeuw PW, Schalekamp MA, Hofman A. Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents. N Engl J Med 1991; 324:1305-1311.
23. Boari GE, Rizzardi N, de Ciuceis C, Platto C, Paiardi S, Porteri E, et al. Determinants of the structure of resistance-sized arteries in hypertensive patients. Blood Press 2008; 17:204-211.
24. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. J Hypertens 1999; 17:151-185.
25. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20:1183-1201.
26. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, et al. Vascular hypertrophy and remodeling in secondary hypertension. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996; 28:785-790.
27. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 1978; 43:854-864.
28. Mulvany MJ, Halpern W. Contractile properties of small resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41:19-26.
29. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470.
30. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A, et al. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non insulin dependent diabetes mellitus. Circulation 2001; 103:1238-1244.
31. Heagerty AM, Aalkjaaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension. Dual process of remodeling and growth. Hypertension 1993; 21:391-397.
32. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 2004; 17(12 Pt 1):1192-1200.
33. Lever AF. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J Hypertens 1986; 4:515-524.
34. Heagerty AM. Predicting hypertension complications from small artery structure. J Hypertens 2007; 25:939-940.
35. Tolbert EM, Weisstuch J, Feiner HD, Dworkin LD. Onset of glomerular hypertension with aging precedes injury in the spontaneously hypertensive rat. Am J Physiol Renal Physiol 2000; 278:F839-F846.
36. Dilley JR, Stier CT Jr, Arendshorst WJ. Abnormalities in glomerular function in rats developing spontaneous hypertension. Am J Physiol 1984; 246:F12-F20.
37. Gattone VH, Evan AP, Willis LR, Luft FC. Renal afferent arterioles in the spontaneously hypertensive rat. Hypertension 1983; 5:8-16.
38. Mezzano S, Ruiz-Ortega M, Egidio I. Angiotensin II and renal fibrosis. Hypertension 2001; 38(Pt2):635-638.
39. Skov K, Nyengaard JR, Korsgaard N, Mulvany MJ. Number and size of renal glomeruli in spontaneously hypertensive rats. J Hypertens 1994; 12:1373-1376.
40. Skov K, Hamet P, Nyengaard JR, Mulvany MJ. Morphology of renal afferent arterioles and glomeruli, heart weight, and blood pressure in primates. Am J Hypertens 2001; 14(4 Pt 1):331-337.
41. Hill GS, Heudes D, Jacquot C, Gauthier E, Bariéty J. Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension. Kidney Int 2006; 69:823-831.
42. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al., RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345:861-869.
43. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
44. Agabiti-Rosei E, Heagerty AM, Rizzoni D. Effects of antihypertensive treatment on small artery remodeling. J Hypertens 2009; 27:1107-1114.
45. K/DOQI Chronic Disease Practice Guidelines for Chronic Kidney Disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39 (Suppl 1):S1-S266.
46. Viazzi F, Leoncini G, Ratto E, Pontremoli R. Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived. J Clin Hypertens (Greenwich) 2006; 8:510-518.
47. Ritt M, Schmieder RE. Wall-to-lumen ratio of retinal arterioles as a tool to assess vascular changes. Hypertension 2009; 54:384-387.
48. Mulvany MJ. Small artery structure: time to take note? Am J Hypertens 2007; 20:853-854.